Clinical trials: Sphenopalatine Ganglion Nerve Block, active
Cluster Headache
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
Cluster headache is a primary headache condition characterized by clusters of one-sided, high-intensity pain attacks. The headache may be episodic or chronic. Treatment options are limited and their effects unsatisfactory.
- Trial name
- BASIC (NCT03944876)
- Testing
- Botulinum toxin type A
- Where
- 5 sites in Germany, Italy and 3 more
- Volunteers
- 112 people
- Sponsor
- Norwegian University of Science and Technology
Sphenopalatine Ganglion Nerve Block, Transnasal Endoscopic Pitutary Surgery
Sphenopalatine Block vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery
Improving pain and surgical field by using sphenopalatine ganglion block and dexmedetomidine in trans-nasal endoscopic pituitary surgery.
- Trial name
- NCT06639659
- Testing
- Sphenopalatine Ganglion Block, Dexmedetomidine, General Anesthesia (control group)
- Where
- Egypt
- Volunteers
- 69 people
- Sponsor
- Zagazig University
Pituitary, Pain, Postoperative
Postop Pain Management in Pituitary Tumour Patients
To assess the benefit of using an additional nerve block during minimally invasive pituitary surgery, to improve pain management after surgery.
- Trial name
- POPPY (NCT06353529)
- Testing
- Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution
- Where
- Canada
- Volunteers
- 108 people
- Sponsor
- Hamilton Health Sciences Corporation
SAH (Subarachnoid Hemorrhage), Headache
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal…
- Trial name
- NCT06621329
- Testing
- Transnasal sphenopalatine ganglion block
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, Davis
Craniotomy Surgery
Sphenopalatine Ganglion Block Combined With Either Scalp Nerve Block or Local Wound Infiltration for Postoperative Analgesia in Adult Patients Undergoing Craniotomy: A Randomized Controlled Trial
The use of multimodal regional analgesia (scalp block, local scalp infiltration, and sphenopalatine ganglion block) for postoperative pain management after craniotomy
- Trial name
- NCT07886034
- Testing
- Group (c): control group patients will receive general anesthesia., Group (SS): Sphenopalatine Ganglion Block with either Scalp Nerve Block, Group (SL): patients will receive Sphenopalatine Ganglion Block with local wound infiltration
- Volunteers
- 54 people
- Sponsor
- Zagazig University